tiprankstipranks
Trending News
More News >
Ryvu Therapeutics SA (DE:9Y4)
FRANKFURT:9Y4
Germany Market

Ryvu Therapeutics SA (9Y4) Ratios

Compare
0 Followers

Ryvu Therapeutics SA Ratios

DE:9Y4's free cash flow for Q3 2024 was zł0.66. For the 2024 fiscal year, DE:9Y4's free cash flow was decreased by zł and operating cash flow was zł-1.63. See a summary of the company’s cash flow.
Ratios
TTM
Dec 23Dec 22Dec 21Dec 20
Liquidity Ratios
Current Ratio
3.99 8.21 2.88 5.10 2.94
Quick Ratio
3.96 8.17 2.83 5.05 2.89
Cash Ratio
0.83 2.27 2.30 4.03 2.36
Solvency Ratio
-0.57 -0.54 -1.09 -0.27 -0.44
Operating Cash Flow Ratio
-1.14 0.48 -1.60 -0.31 -0.57
Short-Term Operating Cash Flow Coverage
-626.26 24.39 -69.47 -13.06 -21.12
Net Current Asset Value
zł 134.78Mzł 236.34Mzł 44.86Mzł 100.44Mzł 26.84M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 0.02 0.03 0.05
Debt-to-Equity Ratio
<0.01 <0.01 0.03 0.03 0.08
Debt-to-Capital Ratio
<0.01 <0.01 0.03 0.03 0.07
Long-Term Debt-to-Capital Ratio
0.00 0.00 <0.01 <0.01 0.02
Financial Leverage Ratio
1.55 1.38 1.35 1.32 1.53
Debt Service Coverage Ratio
-361.80 -35.55 -64.14 -15.76 -34.27
Interest Coverage Ratio
-1.04K -65.82 -394.84 -92.68 -207.25
Debt to Market Cap
<0.01 <0.01 <0.01 <0.01 <0.01
Interest Debt Per Share
0.04 0.21 0.29 0.47 0.59
Net Debt to EBITDA
0.70 1.52 1.19 7.21 1.76
Profitability Margins
Gross Profit Margin
62.54%55.14%-22.69%43.14%-117.82%
EBIT Margin
-196.36%-201.28%-701.92%-196.10%-102.69%
EBITDA Margin
-172.95%-168.04%-589.64%-115.94%-83.92%
Operating Profit Margin
-215.42%-184.71%-696.08%-232.94%-106.04%
Pretax Profit Margin
-196.57%-204.09%-692.08%-198.62%-84.64%
Net Profit Margin
-196.57%-215.91%-693.12%-205.57%-84.57%
Continuous Operations Profit Margin
-196.57%-215.91%-706.91%-205.57%-104.00%
Net Income Per EBT
100.00%105.79%100.15%103.50%99.92%
EBT Per EBIT
91.25%110.49%99.42%85.26%79.82%
Return on Assets (ROA)
-22.85%-17.64%-33.89%-10.72%-19.68%
Return on Equity (ROE)
-35.48%-24.40%-45.76%-14.16%-30.06%
Return on Capital Employed (ROCE)
-30.27%-16.66%-40.43%-13.71%-29.64%
Return on Invested Capital (ROIC)
-30.22%-17.55%-39.92%-14.03%-28.99%
Return on Tangible Assets
-23.21%-17.80%-34.34%-10.80%-20.00%
Earnings Yield
-7.12%-9.28%-6.92%-3.84%-5.01%
Efficiency Ratios
Receivables Turnover
5.10 37.13 0.95 1.94 2.83
Payables Turnover
0.76 1.38 1.17 1.40 6.95
Inventory Turnover
8.29 9.90 7.01 5.23 58.46
Fixed Asset Turnover
0.60 0.47 0.12 0.17 0.64
Asset Turnover
0.12 0.08 0.05 0.05 0.23
Working Capital Turnover Ratio
0.18 0.20 0.11 0.16 0.43
Cash Conversion Cycle
-365.59 -217.06 124.28 -2.74 82.66
Days of Sales Outstanding
71.56 9.83 383.10 188.20 128.97
Days of Inventory Outstanding
44.04 36.89 52.04 69.78 6.24
Days of Payables Outstanding
481.19 263.78 310.85 260.73 52.55
Operating Cycle
115.60 46.72 435.13 257.99 135.22
Cash Flow Ratios
Operating Cash Flow Per Share
-3.47 1.16 -3.15 -0.63 -1.09
Free Cash Flow Per Share
-3.85 0.66 -3.81 -2.67 -2.59
CapEx Per Share
0.37 0.51 0.65 2.04 1.50
Free Cash Flow to Operating Cash Flow
1.11 0.56 1.21 4.21 2.38
Dividend Paid and CapEx Coverage Ratio
-9.27 2.30 -4.83 -0.31 -0.73
Capital Expenditure Coverage Ratio
-9.27 2.30 -4.83 -0.31 -0.73
Operating Cash Flow Coverage Ratio
-87.79 7.70 -11.41 -1.44 -1.89
Operating Cash Flow to Sales Ratio
-1.70 0.55 -5.17 -0.69 -0.41
Free Cash Flow Yield
-6.81%1.33%-6.24%-5.43%-5.76%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-14.05 -10.78 -14.44 -26.03 -19.96
Price-to-Sales (P/S) Ratio
27.61 23.27 100.09 53.51 16.88
Price-to-Book (P/B) Ratio
4.98 2.63 6.61 3.69 6.00
Price-to-Free Cash Flow (P/FCF) Ratio
-14.68 75.05 -16.03 -18.41 -17.36
Price-to-Operating Cash Flow Ratio
-16.27 42.36 -19.35 -77.56 -41.30
Price-to-Earnings Growth (PEG) Ratio
1.17 -1.30 -0.12 1.63 >-0.01
Price-to-Fair Value
4.98 2.63 6.61 3.69 6.00
Enterprise Value Multiple
-15.26 -12.33 -15.79 -38.95 -18.36
Enterprise Value
EV to EBITDA
-15.26 -12.33 -15.79 -38.95 -18.36
EV to Sales
26.39 20.72 93.11 45.16 15.41
EV to Free Cash Flow
-14.04 66.81 -14.91 -15.53 -15.84
EV to Operating Cash Flow
-15.55 37.70 -18.00 -65.45 -37.69
Tangible Book Value Per Share
11.06 18.50 9.06 13.21 7.32
Shareholders’ Equity Per Share
11.34 18.73 9.23 13.34 7.50
Tax and Other Ratios
Effective Tax Rate
0.00 -0.06 >-0.01 -0.04 <0.01
Revenue Per Share
2.05 2.12 0.61 0.92 2.67
Net Income Per Share
-4.02 -4.57 -4.22 -1.89 -2.25
Tax Burden
1.00 1.06 1.00 1.04 1.00
Interest Burden
1.00 1.01 0.99 1.01 0.82
Research & Development to Revenue
0.00 0.67 1.34 0.84 1.59
SG&A to Revenue
0.00 0.14 0.39 0.35 0.53
Stock-Based Compensation to Revenue
0.00 0.57 2.06 0.00 0.00
Income Quality
0.86 -0.25 0.75 0.34 0.48
Currency in PLN
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis